Logotype for Philip Morris International Inc

Philip Morris International (PM) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Philip Morris International Inc

Q4 2025 earnings summary

21 Apr, 2026

Executive summary

  • Achieved fifth consecutive year of volume growth, with net revenues surpassing $40 billion and smoke-free products contributing 41.5% of total net revenues for 2025, available in 106 markets and representing over 50% of net revenues in 27 markets and 3 of 4 regions.

  • Adjusted diluted EPS grew 14.8% year-over-year to $7.54, the strongest since 2011 (excluding 2021), with operating income margin above 40%.

  • Smoke-free shipment volumes rose 12.8%, with over 43 million adult consumers globally.

  • Consistent, best-in-class growth and commitment to rewarding shareholders, with confidence in outlook for 2026 and beyond.

  • Strong international performance, with ZYN shipments in the U.S. up 37% and robust growth in wellness and combustibles despite supply constraints.

Financial highlights

  • Full-year 2025 net revenues reached $40.6 billion, up 7.3% reported and 6.5% organically; Q4 organic net revenues grew 3.7% to $10.4 billion.

  • Gross profit was $27.3 billion, up 11.1% reported and 10.1% organically; operating income was $14.9 billion, up 11.1% reported and 10.6% organically.

  • Adjusted operating income margin for 2025 was 40.4%, up 1.6pp from 2024, with gross margin improved by 140 basis points.

  • Adjusted diluted EPS for 2025 was $7.54, up 14.8% year-over-year and 14.2% on a currency-neutral basis.

  • Operating cash flow for 2025 was $12.2 billion, matching the prior year.

Outlook and guidance

  • 2026 organic net revenue growth forecast at 5%–7%, with organic operating income growth of 7%–9%.

  • 2026 adjusted diluted EPS forecasted at $8.38–$8.53, representing 11.1%–13.1% growth over 2025, with currency-neutral growth of 7.5%–9.5%.

  • Operating cash flow for 2026 projected at approximately $13.5 billion, with net debt to adjusted EBITDA targeted near 2.0x by year-end.

  • 2026–2028 guidance targets 6%–8% net revenue CAGR, 8%–10% operating income CAGR, and 9%–11% adjusted diluted EPS CAGR (currency-neutral).

  • Capital expenditures projected at $1.4–$1.6 billion in 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more